Showing 1 to 8 of 8
| Title | Reference number | Reference number sort | Published | Published date sort | Last updated | Last updated sort |
|---|---|---|---|---|---|---|
| Physical activity: brief advice for adults in primary care | Reference number:PH44 | PH00044 | Published:29 May 2013 | 20130501 | Last updated:29 May 2013 | 20130529 |
| Social anxiety disorder: recognition, assessment and treatment | Reference number:CG159 | CG00159 | Published:22 May 2013 | 20130501 | Last updated:22 May 2013 | 20130522 |
| Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion | Reference number:TA283 | TA00283 | Published:22 May 2013 | 20130501 | Last updated:22 May 2013 | 20130522 |
| Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer | Reference number:TA284 | TA00284 | Published:22 May 2013 | 20130501 | Last updated:22 May 2013 | 20130522 |
| Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer | Reference number:TA285 | TA00285 | Published:22 May 2013 | 20130501 | Last updated:22 May 2013 | 20130522 |
| Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal) | Reference number:TA286 | TA00286 | Published:22 May 2013 | 20130501 | Last updated:22 May 2013 | 20130522 |
| Generalised anxiety disorder: quetiapine | Reference number:ESUOM12 | ESUOM00012 | Published:15 May 2013 | 20130501 | Last updated:15 May 2013 | 20130515 |
| Attention deficit hyperactivity disorder in children and young people: lisdexamfetamine dimesylate | Reference number:ESNM19 | ESNM00019 | Published:07 May 2013 | 20130501 | Last updated:07 May 2013 | 20130507 |